New Harbor Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Buy
+146,497
New +$19.8M 3.66% 14
2013
Q4
Sell
-600
Closed -$26K 108
2013
Q3
$26K Hold
600
0.03% 44
2013
Q2
$21K Buy
+600
New +$21.1K 0.03% 53

Other funds holding XBI

New Harbor Financial Group's XBI Position: Q2 2026 in Review

New Harbor Financial Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 146,497 shares worth $23.2M. The stake represents 3.66% of the portfolio and ranks #14 among its holdings. This is a return to the name: New Harbor Financial Group previously reported a position in XBI as recently as Q3 2013.

New Harbor Financial Group first reported a position in XBI in Q2 2013 and has held it in 3 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • New Harbor Financial Group held 146,497 shares of State Street SPDR S&P Biotech ETF worth $23.2M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new New Harbor Financial Group position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 3.66% of New Harbor Financial Group's portfolio in Q2 2026, its #14 holding.
  • New Harbor Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 3 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on New Harbor Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.